These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28880825)

  • 1. Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment.
    Defreyne J; Nota N; Pereira C; Schreiner T; Fisher AD; den Heijer M; T'Sjoen G
    LGBT Health; 2017 Oct; 4(5):328-336. PubMed ID: 28880825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.
    Fung R; Hellstern-Layefsky M; Tastenhoye C; Lega I; Steele L
    J Sex Med; 2016 Nov; 13(11):1765-1772. PubMed ID: 27693265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
    Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G
    Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.
    Nota NM; Dekker MJHJ; Klaver M; Wiepjes CM; van Trotsenburg MA; Heijboer AC; den Heijer M
    Andrologia; 2017 Aug; 49(6):. PubMed ID: 27561756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study.
    Kuijpers SME; Wiepjes CM; Conemans EB; Fisher AD; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3936-e3945. PubMed ID: 34125226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
    Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Cyproterone Acetate Treatment for Transgender Women.
    Even Zohar N; Sofer Y; Yaish I; Serebro M; Tordjman K; Greenman Y
    J Sex Med; 2021 Jul; 18(7):1292-1298. PubMed ID: 34176757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents.
    Tack LJW; Heyse R; Craen M; Dhondt K; Bossche HV; Laridaen J; Cools M
    J Sex Med; 2017 May; 14(5):747-757. PubMed ID: 28499525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.
    Cunha FS; Domenice S; Sircili MHP; Mendonca BB; Costa EMF
    Clinics (Sao Paulo); 2018; 73():e86. PubMed ID: 29723345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
    Burinkul S; Panyakhamlerd K; Suwan A; Tuntiviriyapun P; Wainipitapong S
    J Sex Med; 2021 Jul; 18(7):1299-1307. PubMed ID: 34274044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
    van Wayjen RG; van den Ende A
    Exp Clin Endocrinol Diabetes; 1995; 103(4):241-51. PubMed ID: 7584530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy.
    Collet S; Gieles NC; Wiepjes CM; Heijboer AC; Reyns T; Fiers T; Lapauw B; den Heijer M; T'Sjoen G
    J Clin Endocrinol Metab; 2023 Jan; 108(2):331-338. PubMed ID: 36201493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen.
    Gava G; Mancini I; Alvisi S; Seracchioli R; Meriggiola MC
    Eur J Endocrinol; 2020 Dec; 183(6):561-569. PubMed ID: 33055297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerning the Article by Fung et al, Titled "Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
    Defreyne J; T'Sjoen G
    J Sex Med; 2017 Jan; 14(1):172-173. PubMed ID: 28065354
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to "Letter to the Editor Concerning the Paper by Fung et al titled 'Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
    Fung R; Lega I
    J Sex Med; 2017 Jan; 14(1):173-174. PubMed ID: 28065355
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
    Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
    J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness.
    Gava G; Cerpolini S; Martelli V; Battista G; Seracchioli R; Meriggiola MC
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):239-46. PubMed ID: 26932202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.